Jeremy Farrar

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Jeremy Farrar
Jeremy Farrar C0058569 Wellcome Images.jpg
Jeremy Farrar in 2009, portrait via wellcomeimges.org at the Wellcome Trust
Born Jeremy James Farrar
Fields
Institutions
Alma mater
Thesis Analysis of combinatorial immunoglobin libraries from a myasthenia gravis patient (1997)
Doctoral students
  • Jane Chun[6]
  • Abhilasha Karkey[7]
  • Vianney Tricou[8]
Influences Cheryll Tickle[9][10]
Notable awards
Website

Jeremy James Farrar FRCP FMedSci OBE is a Professor of Tropical medicine at the University of Oxford and director of the Wellcome Trust, one of world’s largest and wealthiest research charities.[13][14][15][16][4][17][18][19]

Education[edit]

Farrar was educated at University College London Medical School,[9] from where he obtained a Bachelor of Science degree in Immunology in 1983 and a Bachelor of Medicine, Bachelor of Surgery in 1986.[5] Farrar completed his Doctor of Philosophy degree at the University of Oxford in 1998 on myasthenia gravis.[20]

Career[edit]

Prior to leading the Wellcome Trust, Farrar was Director of the Oxford University Clinical Research Unit in Vietnam.[2][21][22][23][24]

Research[edit]

Farrar's research interests are in infectious diseases[9] such Tuberculosis,[25] Dengue,[26][27][28][29] Typhoid fever, Malaria, and Influenza H5N1.[30][31][32][33][1]

Awards and honours[edit]

Farrar is a member of the Royal College of Physicians (MRCP) and the Academy of Medical Sciences (FMedSci) and an Officer of the Most Excellent Order of the British Empire (OBE). His citation on election to the Academy of Medical Sciences reads:

References[edit]

  1. ^ a b Woolhouse, Mark; Farrar, Jeremy (2014). "Policy: An intergovernmental panel on antimicrobial resistance". Nature 509 (7502): 555. doi:10.1038/509555a. 
  2. ^ a b http://www.oucru.org
  3. ^ The Farrar Foundation, farrarfoundation.org
  4. ^ a b Farrar, J; Cressey, D (2014). "Straight talk with...Jeremy Farrar". Nature Medicine 20 (2): 112. doi:10.1038/nm0214-112. PMID 24504397. 
  5. ^ a b Jeremy Farrar, BSc MBBS FRCP DPhil, antimicrobe.org
  6. ^ Chun, Jane M (2014). Livelihoods under stress: household assets and responses to environmental change in the Mekong Delta, Vietnam (DPhil thesis). University of Oxford. 
  7. ^ Karkey, Abhilasha (2012). Evaluation of strain circulation and the epidemiology of enteric fever caused (DPhil thesis). University of Oxford. 
  8. ^ Tricou, Vianney M (2011). Dengue diagnostics and therapeutic interventions in Viet Nam (DPhil thesis). University of Oxford. 
  9. ^ a b c Jeremy Farrar Interviewed by Jim Al-Khalili on The Life Scientific, 2014-07-14
  10. ^ Tickle, C; Crawley, A; Farrar, J (1989). "Retinoic acid application to chick wing buds leads to a dose-dependent reorganization of the apical ectodermal ridge that is mediated by the mesenchyme". Development (Cambridge, England) 106 (4): 691–705. PMID 2562664. 
  11. ^ a b Jeremy Farrar - Epidemiologist, BBC World Service
  12. ^ a b "Dr Jeremy Farrar OBE FMedSci". London: Academy of Medical Sciences. Archived from the original on 2014-09-25. 
  13. ^ Van Noorden, Richard (2013). "Clinician to head Wellcome Trust: Jeremy Farrar to lead one of world’s largest research charities.". Nature 497 (7447): 19. doi:10.1038/497019a. 
  14. ^ Maxmen, A. (2009). "Jeremy Farrar: When disaster strikes". Journal of Experimental Medicine 206 (1): 4–5. doi:10.1084/jem.2061pi. PMC 2626674. PMID 19153250. 
  15. ^ A very Wellcome appointment: Professor Jeremy Farrar, who takes over as director of the Wellcome Trust in October 2013, The Guaridan, 2013-04-25
  16. ^ Jeremy Farrar from the Scopus bibliographic database.
  17. ^ Jeremy Farrar on Twitter
  18. ^ Pouplin, T.; Phuong, P. N.; Toi, P. V.; Nguyen Pouplin, J.; Farrar, J. (2014). "Isoniazid, Pyrazinamide and Rifampicin Content Variation in Split Fixed-Dose Combination Tablets". PLoS ONE 9 (7): e102047. Bibcode:2014PLoSO...9j2047P. doi:10.1371/journal.pone.0102047. PMID 25004128. 
  19. ^ Gilbert, M.; Golding, N.; Zhou, H.; Wint, G. R. W.; Robinson, T. P.; Tatem, A. J.; Lai, S.; Zhou, S.; Jiang, H.; Guo, D.; Huang, Z.; Messina, J. P.; Xiao, X.; Linard, C.; Van Boeckel, T. P.; Martin, V.; Bhatt, S.; Gething, P. W.; Farrar, J. J.; Hay, S. I.; Yu, H. (2014). "Predicting the risk of avian influenza a H7N9 infection in live-poultry markets across Asia". Nature Communications 5. doi:10.1038/ncomms5116. 
  20. ^ Farrar, Jeremy (1997). Analysis of combinatorial immunoglobin libraries from a myasthenia gravis patient (DPhil thesis). University of Oxford. 
  21. ^ Watts, G (2013). "Jeremy Farrar: Wellcome arrival from southeast Asia". The Lancet 382 (9899): 1167. doi:10.1016/S0140-6736(13)62047-4. PMID 24095187. 
  22. ^ Jeremy Farrar on Connecting your research with society on YouTube
  23. ^ Exchanges at the Frontier: Jeremy Farrar on YouTube
  24. ^ Jeremy Farrar seeks innovative backgrounds to help fight infectious diseases, Wired UK on YouTube
  25. ^ Thwaites, G. E.; Nguyen, N. D.; Nguyen, N. H.; Hoang, H. T.; Do, D. T. T.; Nguyen, N. T. C.; Nguyen, N. Q.; Nguyen, N. T.; Nguyen, N. N.; Nguyen, N. T. N.; Nguyen, N. N.; Nguyen, N. H.; Vu, V. N.; Cao, C. H.; Tran, T. T. H.; Pham, P. P.; Nguyen, N. T.; Stepniewska, K.; White, N. J.; Tran, T. T.; Farrar, J. J. (2004). "Dexamethasone for the Treatment of Tuberculous Meningitis in Adolescents and Adults". New England Journal of Medicine 351 (17): 1741–1751. doi:10.1056/NEJMoa040573. PMID 15496623. 
  26. ^ Tricou, V.; Vu, H. T.; Quynh, N. V.; Nguyen, C. V.; Tran, H. T.; Farrar, J.; Wills, B.; Simmons, C. P. (2010). "Comparison of two dengue NS1 rapid tests for sensitivity, specificity and relationship to viraemia and antibody responses". BMC Infectious Diseases 10: 142. doi:10.1186/1471-2334-10-142. PMC 2895602. PMID 20509940. 
  27. ^ Guzman, M. G.; Halstead, S. B.; Artsob, H.; Buchy, P.; Farrar, J.; Gubler, D. J.; Hunsperger, E.; Kroeger, A.; Margolis, H. S.; Martínez, E.; Nathan, M. B.; Pelegrino, J. L.; Simmons, C.; Yoksan, S.; Peeling, R. W. (2010). "Dengue: A continuing global threat". Nature Reviews Microbiology 8 (12): S7–16. doi:10.1038/nrmicro2460. PMID 21079655. 
  28. ^ Wills, B. A.; Dung, N. M.; Loan, H. T.; Tam, D. T. H.; Thuy, T. T. N.; Minh, L. T. T.; Diet, T. V.; Hao, N. T.; Chau, N. V.; Stepniewska, K.; White, N. J.; Farrar, J. J. (2005). "Comparison of Three Fluid Solutions for Resuscitation in Dengue Shock Syndrome". New England Journal of Medicine 353 (9): 877–89. doi:10.1056/NEJMoa044057. PMID 16135832. 
  29. ^ Solomon, T.; Dung, N. M.; Vaughn, D. W.; Kneen, R.; Thao, L. T. T.; Raengsakulrach, B.; Loan, H. T.; Day, N. P.; Farrar, J.; Myint, K. S.; Warrell, M. J.; James, W. S.; Nisalak, A.; White, N. J. (2000). "Neurological manifestations of dengue infection". The Lancet 355 (9209): 1053–1059. doi:10.1016/S0140-6736(00)02036-5. PMID 10744091. 
  30. ^ Farrar, J. (2012). "H5N1 surveillance: Shift expertise to where it matters". Nature 483 (7391): 534–535. doi:10.1038/483534a. PMID 22460881. 
  31. ^ Hien, T. T.; Nguyen, N. T.; Nguyen, N. T.; Luong, L. T.; Pham, P. P.; Nguyen, N. V. V.; Pham, P. T.; Vo, V. C.; Le, L. T. Q.; Ngo, N. T.; Dao, D. B.; Le, L. P.; Nguyen, N. T.; Hoang, H. T.; Cao, C. V.; Le, L. T.; Nguyen, N. D.; Le, L. H.; Nguyen, N. T. K.; Le, L. H.; Le, L. V.; Christiane, C.; Tran, T. T.; Menno De, M.; Schultsz, C.; Cheng, P.; Lim, W.; Horby, P.; Farrar, J.; World Health Organization International Avian Influenza Investigative Team (2004). "Avian Influenza A (H5N1) in 10 Patients in Vietnam". New England Journal of Medicine 350 (12): 1179–1188. doi:10.1056/NEJMoa040419. PMID 14985470. 
  32. ^ De Jong, M. D.; Simmons, C. P.; Thanh, T. T.; Hien, V. M.; Smith, G. J. D.; Chau, T. N. B.; Hoang, D. M.; Chau, N.; Khanh, T. H.; Dong, V. C.; Qui, P. T.; Cam, B.; Ha Do, D. Q.; Guan, Y.; Peiris, J. S. M.; Chinh, N. T.; Hien, T. T.; Farrar, J. (2006). "Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia". Nature Medicine 12 (10): 1203–1207. doi:10.1038/nm1477. PMID 16964257. 
  33. ^ List of publications from Microsoft Academic Search



Cultural offices
Preceded by
Mark Walport
Director of the Wellcome Trust
2013 – date
Incumbent